CME INDIA
  • Home
  • CME INDIA Repository
  • CME INDIA Case Study
  • History Today in Medicine
  • Future CMEs
  • About CME INDIA
Select Page
New Drug Semaglutide in T2 Diabetes – What A Physician Must Know?

New Drug Semaglutide in T2 Diabetes – What A Physician Must Know?

by Admin | Jun 18, 2022 | CME INDIA Repository

CME INDIA Presentation by Dr. N. K. Singh, MD, FICP, Director, Diabetes and Heart Research Centre, Dhanbad, Jharkhand, India. Editor, www.cmeindia.in. CME INDIA Discussion (08/04/2022) Dr. Awadhesh K. Singh, DM Endo., Kolkata: On Semaglutide (Rybelsus) (3-7 mg) plus...

Latest Comments

  • Dr.Subhankar Das on Is SGLT2-Inhibitors a New Nectar in Renal Protection in Diabetes?
  • Dr pradeep Sahay on History Today in Medicine – Dr. Candace Pert
  • Arjun Kakrani on History Today in Medicine – Dr. Ramachandra Dattatraya Lele
  • Dr Bhuraj Sane on History Today in Medicine – Dr. Ramachandra Dattatraya Lele
  • Dr J k Barpuzari on A Very Distressing Sore Throat? Assume That It’s COVID-19

Latest Posts

  • History Today in Medicine – Dr. Robert Edward Gross
  • History Today in Medicine – Dr. Bidhan Chandra Roy
  • History Today in Medicine – Joseph Caventou
  • Whenever Child Passes Urine, It Turns Black: Spot the Diagnosis
  • History Today in Medicine – Dr. William James Mayo

Explore CME INDIA

  • About CME INDIA
  • CME INDIA Case Study
  • CME INDIA Downloads
  • CME INDIA Home
  • CME INDIA Repository
  • Future CMEs
  • History Today in Medicine
  • What is CME?
© CME INDIA 2022. All content on this site is for academic discussion only. Propelled by Dynamic Cognition.